Get the Stockscreener App
6.10
2.40%
-0.15
After Hours:
6.15
0.05
+0.82%
Certara Inc stock is traded at $6.10, with a volume of 3.41M.
It is down -2.40% in the last 24 hours and down -7.44% over the past month.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
See More
Previous Close:
$6.25
Open:
$6.34
24h Volume:
3.41M
Relative Volume:
1.18
Market Cap:
$970.75M
Revenue:
$418.84M
Net Income/Loss:
$-1.60M
P/E Ratio:
-592.23
EPS:
-0.0103
Net Cash Flow:
$69.77M
1W Performance:
-6.15%
1M Performance:
-7.44%
6M Performance:
-47.16%
1Y Performance:
-40.89%
1-Day Range:
$6.09
$6.42
1-Week Range:
$6.02
$6.67
52-Week Range:
$6.02
$15.38
Certara Inc Stock (CERT) Company Profile
Name
Certara Inc
Sector
Industry
Phone
(415) 237-8272
Address
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Compare CERT vs VEEV, BTSG, TEM, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
6.10 | 994.62M | 418.84M | -1.60M | 69.77M | -0.0103 |
VEEV
Veeva Systems Inc
|
178.11 | 29.44B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
44.82 | 8.32B | 12.91B | 104.80M | 394.69M | 0.8769 |
TEM
Tempus Ai Inc
|
46.76 | 8.73B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
82.47 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
24.14 | 4.61B | 1.10B | 112.09M | 283.19M | 0.6096 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-27-26 | Downgrade | Craig Hallum | Buy → Hold |
| Jan-06-26 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Nov-21-25 | Initiated | Rothschild & Co Redburn | Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Sep-29-25 | Initiated | Craig Hallum | Buy |
| Jul-03-25 | Resumed | Morgan Stanley | Equal-Weight |
| May-08-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Feb-27-25 | Initiated | TD Cowen | Buy |
| Sep-27-24 | Upgrade | UBS | Neutral → Buy |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-04-24 | Initiated | JMP Securities | Mkt Perform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Aug-22-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-10-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Apr-03-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-08-22 | Initiated | Berenberg | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-01-22 | Initiated | Piper Sandler | Overweight |
| Jan-11-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-23-21 | Initiated | Robert W. Baird | Outperform |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-06-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-05-21 | Initiated | BofA Securities | Buy |
| Jan-05-21 | Initiated | Credit Suisse | Neutral |
| Jan-05-21 | Initiated | Jefferies | Hold |
| Jan-05-21 | Initiated | William Blair | Outperform |
View All
Certara Inc Stock (CERT) Latest News
When Will Certara, Inc. (NASDAQ:CERT) Become Profitable? - 富途牛牛
If You Invested $1,000 in Certara, Inc. (CERT) - Stock Titan
Certara (NASDAQ:CERT) Sets New 1-Year LowHere's Why - MarketBeat
Understanding Momentum Shifts in (CERT) - Stock Traders Daily
Sentiment Review: Is Certara Inc being accumulated by smart moneyMarket Activity Recap & Daily Profit Focused Stock Screening - baoquankhu1.vn
Buy Signal: Whats the RSI of Certara Inc stock2026 WrapUp & Real-Time Market Trend Scan - baoquankhu1.vn
Certara, Inc. $CERT Stock Position Boosted by Kopion Asset Management LLC - MarketBeat
Market Wrap: Can Certara Inc lead its sector in growthWeekly Profit Recap & High Yield Equity Trading Tips - baoquankhu1.vn
CERT SEC FilingsCertara, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Assessing Certara (CERT) Valuation After FDA PBPK Milestone And New Biosimulation Software Launches - simplywall.st
Certara, Inc. $CERT is ArrowMark Colorado Holdings LLC's 5th Largest Position - MarketBeat
Is Certara (CERT) Offering Opportunity After Prolonged Share Price Weakness - Yahoo Finance
Topline Capital Management LLC Purchases Shares of 546,471 Certara, Inc. $CERT - MarketBeat
Brown Brothers Harriman & Co. Has $46 Million Holdings in Certara, Inc. $CERT - MarketBeat
Alpha Wave Global LP Takes Position in Certara, Inc. $CERT - MarketBeat
Certara Conference: 2025 revenue hits guidance, EBITDA margin tops range as Q4 software bookings slip - MarketBeat
Certara Details 2026 Outlook at Leerink Conference as Software Bookings Slow, AI Push Builds - MarketBeat
Certara (CERT) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
Avoiding Lag: Real-Time Signals in (CERT) Movement - Stock Traders Daily
Certara at Barclays Healthcare Conference: Strategic Growth and AI Integration - Investing.com South Africa
Dixon Mitchell Investment Counsel Inc. Purchases Shares of 866,380 Certara, Inc. $CERT - MarketBeat
Certara at Leerink Conference: Strategic Moves Amid Challenges By Investing.com - Investing.com South Africa
Certara at Leerink Conference: Strategic Moves Amid Challenges - Investing.com
Certara, Inc. (NASDAQ:CERT) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
How Investors Are Reacting To Certara (CERT) FDA Acceptance Of Simcyp In Place Of Clinical Trials - simplywall.st
Assessing Certara (CERT) Valuation After FDA PBPK Milestone And Latest Earnings Guidance - Sahm
Certara CEO Resnick Teases Regulatory Services Decision, Phoenix Cloud Push at TD Cowen Conference - Yahoo Finance
Certara appoints Jon Resnick as new CEO; reaffirms FY25 outlook - MSN
Earnings estimates moving higher for Certara (CERT): Time to buy? - MSN
Will Certara Inc. stock outperform international peers2025 EndofYear Setup & Short-Term Trading Alerts - Naître et grandir
CERTCertara Inc Stock Price and Quote - Finviz
Certara, Inc. (CERT): Analysts Assign Equal-Weight Rating Amid Price Stagnation - 富途牛牛
Certara (CERT) Downgraded to Equal-Weight by Barclays | CERT Sto - GuruFocus
Certara's (CERT) Equal Weight Rating Reiterated at Barclays - MarketBeat
Forecasting The Future: 7 Analyst Projections For Certara - Benzinga
Barclays downgrades Certara stock rating on turnaround concerns By Investing.com - Investing.com South Africa
Barclays downgrades Certara stock rating on turnaround concerns - Investing.com
Certara at TD Cowen Conference: Strategic Focus and AI Integration By Investing.com - Investing.com Canada
Certara at TD Cowen Conference: Strategic Focus and AI Integration - Investing.com UK
Certara (CERT) Gains FDA Acceptance for PBPK Modeling in Drug Ap - GuruFocus
Certara, Inc. (CERT) Stock Analysis: Exploring a 38% Potential Upside in Health Information Services - DirectorsTalk Interviews
CERT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Certara Simcyp® simulator results replace ten human trials for chronic myeloid leukemia (CML) therapy asciminib - marketscreener.com
Certara Simcyp Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib - Bitget
Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib - The Manila Times
FDA accepts virtual-patient data so leukemia drug avoids 10 trials - Stock Titan
Certara, Inc. $CERT Stock Holdings Boosted by Roubaix Capital LLC - MarketBeat
Certara Earnings Call: Software Strength Amid Transition - The Globe and Mail
Certara (CERT) director granted 5,547 restricted stock units - Stock Titan
Certara (CERT) director Arjun Bedi submits initial Form 3 insider filing - Stock Titan
Certara Inc Stock (CERT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.33%
5.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):